Senior Medical Advisor AT1D , North Europe

• Location: Sweden, Belgium, Denmark, Finland, Netherlands, Norway
• Job type: Fulltime, Permanent

About the job

Our Team

At Sanofi, we are driven by one purpose – we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We never settle and now we are creating a new paradigm with a first-in-class therapy in Autoimmune Diabetes (Type 1 Diabetes).

Our newest core asset, resulting from the acquisition of Provention Bio in General Medicines Autoimmune Type 1 Diabetes space, aims at delaying the onset of stage 3 type 1 diabetes. This means that for the first time, people at risk of developing this lifelong disease have fresh hope. What delayed onset means is more time for children to be children with less healthcare and more care-free childhood. The delay also gives families and healthcare professionals more time to prepare care plans for a later diagnosis.

We now present an exciting opportunity for you to go further faster. If you’re excited by the prospect of bringing this innovative, first-in-class therapy to more people at risk then we want to hear from you as we build a great team who will work at the intersection of our growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet need.

This is a chance to bring your energy, expertise and experience to truly transformative and career-defining leadership roles where you can help change countless lives. In return, you will have a rare opportunity in pharma – the chance to help disrupt and delay a debilitating and widespread disease.

This really is a ‘prime time’ role offering you huge visibility and the chance to fast-track your career in healthcare.

Innovation, patient focus and disruptive thinking are all key threads of our Play To Win culture.

Our Autoimmune Type 1 Diabetes journey starts now and you can help us chart a new course – not only for Sanofi but for preventive healthcare. Now is the time to add your strengths to ours!

Main responsibilities

We are seeking a highly motivated and visionary leader interested in shaping the management of people at risk of developing/or with T1 diabetes.

As the Senior Medical Advisor AT1D, you will be primarily responsible to co-build and adapt the Glocal Medical Strategy to your countries context and drive the scientific community consensus around a first-in-class therapy in Autoimmune Type 1 Diabetes.

Reporting to the Medical Lead Autoimmune T1D, this role is strategically positioned to realize the ambition for T1D and contribute to the overall future success of Sanofi.

Your core responsibilities will include

• Co-building with Global Medical team (GMT) the Global Medical strategy (Integrated Growth Plan), providing local insights (e.g., on screening and infrastructure maturity, T1D awareness and knowledge levels, etc.) to inform the strategic development process
• Developing, in collaboration with cross-functional teams, a local multi-factorial stakeholder engagement strategy for a broad stakeholder ecosystem (incl. KOLs, DOLs, HCPs, PAGs, governments, payers, think tanks, scientific societies, investigators, etc.) by understanding how they impact each other and ensuring engagement strategy is tailored to each segment
• Engaging with appropriate Type I Diabetes stakeholders to understand the state of healthcare policies and guidelines as they relate to clinical practices at national level
• Engaging with Scientific Societies and National KOLs to build champion networks and drive consensus around the value of screening and the establishment of guidelines to make screening a national practice
• With cross-functional teams, building long-term partnerships with key national stakeholders in screening and monitoring environments (e.g., governments, diagnostic labs, think tanks, newborn genetic testing companies)
• Localizing global content and medical messaging (when appropriate) leveraging innovative value story techniques to ensure a compelling narrative on value and outcomes is available at country level and tailored to the different segments of customers based on local go-to-market model
• Building on global framework and compelling narrative, adapting communication strategy around screening, T1D and treatment options
• Leading medical and scientific congresses and advisory boards to capture insights (e.g., on current practices, perception of T1D burden, emerging treatment options, studies endpoints and outcomes, potential label expansions, etc.) and translate insights into medical strategy
• Keeping up-to-date about medical and